Intrexon | XON - PE Price to Earnings


Intrexon reported 7.54 in PE Price to Earnings for its fiscal quarter ending in December of 2021.





Pe Change Date
Amgen 19.84 5.47 Mar/2026
Anika Therapeutics 47.54 27.2 Jun/2024
AstraZeneca 29.59 2.3 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Incyte 15.35 0.51 Mar/2026
Intrexon 7.54 221.44 Dec/2021
Ligand Pharmaceuticals 56.5 26.8 Mar/2026
MannKind 201.15 102.55 Mar/2026
Merck 16.52 2.6 Mar/2026
Novartis 20.17 2.32 Mar/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Roche Holding 16.09 3.51 Dec/2025
Thermo Fisher Scientific 27.71 3.29 Mar/2026
Veracyte 24.89 20.41 Mar/2026
Xencor 29.92 3.22 Sep/2022